Karyopharm Therapeutics (KPTI) EBITDA Margin (QoQ) (2012 - 2025)
Karyopharm Therapeutics (KPTI) EBITDA Margin (QoQ) (2012 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Karyopharm Therapeutics |
95.31 Mn |
31.56 Mn |
32.74 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
12,759.00 |
| Sep 30, 2025 |
2,974.00 |
| Jun 30, 2025 |
4,650.00 |
| Mar 31, 2025 |
-838.00 |
| Dec 31, 2024 |
-3,465.00 |
| Sep 30, 2024 |
-205.00 |
| Jun 30, 2024 |
3,619.00 |
| Mar 31, 2024 |
1,012.00 |
| Dec 31, 2023 |
-2,522.00 |
| Sep 30, 2023 |
-812.00 |
| Jun 30, 2023 |
115.00 |
| Mar 31, 2023 |
2,101.00 |
| Dec 31, 2022 |
-1,554.00 |
| Sep 30, 2022 |
2,282.00 |
| Jun 30, 2022 |
-3,558.00 |
| Mar 31, 2022 |
-10,974.00 |
| Dec 31, 2021 |
15,344.00 |
| Sep 30, 2021 |
10,077.00 |
| Jun 30, 2021 |
815.00 |
| Mar 31, 2021 |
-11,956.00 |
